本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、误导性陈 述或重大遗漏。 证券代码：300753 证券简称：爱朋医疗 公告编号：2025-038 江苏爱朋医疗科技股份有限公司 关于召开 2025 年第一次临时股东会的通知 江苏爱朋医疗科技股份有限公司（以下简称"公司"）于 2025 年 7 月 18 日召开了第 三届董事会第十二次会议，决定于 2025 年 8 月 5 日（星期二）15:00 召开 2025 年第一次临 时股东会（以下简称"本次会议"）。现将会议的有关情况通知如下： 一、召开会议的基本情况 1、股东会届次：2025 年第一次临时股东会 2、股东会召集人：公司董事会 3、会议召开的合法、合规性： 公司于 2025 年 7 月 18 日召开了第三届董事会第十二次会议，审议通过了《关于召开 2025 年第一次临时股东会的议案》，本次股东会的召集符合《公司法》等法律法规及《公 司章程》的规定。 4、会议召开的时间 （1）现场会议召开时间为：2025 年 8 月 5 日（星期二）15:00。 （2）网络投票时间为：通过深圳证券交易所交易系统进行网络投票的具体时间为： 2025 年 8 ...

江苏爱朋医疗科技股份有限公司（以下简称"公司"）第三届董事会第十二次会议通 知及会议材料于2025年7月13日以邮件形式向公司全体董事发出，会议于2025年7月18日在 上海市闵行区联航路1188号3号楼公司会议室以现场结合通讯的方式召开。本次会议应出 席董事7人，实际出席董事7人，部分高级管理人员列席了本次会议。会议由董事长王凝宇 先生召集和主持，本次会议符合《公司法》等相关法律法规以及《公司章程》的相关规定。 江苏爱朋医疗科技股份有限公司 二、董事会会议审议情况 本次会议以记名方式投票表决，逐项审议以下议案： 第三届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、董事会会议召开情况 证券代码：300753 证券简称：爱朋医疗 公告编号：2025-028 1、审议通过《关于董事会换届选举暨提名第四届董事会非独立董事候选人的议案》 鉴于公司第三届董事会任期将于 2025 年 8 月 5 日届满，根据《公司法》《深圳证券 交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板 上市公司规范运作》等法律法 ...

江苏爱朋医疗科技股份有限公司 关于公司高级管理人员减持股份预披露的公告 公司高级管理人员李庆先生保证向公司提供的信息内容真实、准确和完 整，没有虚假记载、误导性陈述或者重大遗漏。 证券代码：300753 证券简称：爱朋医疗 公告编号：2025-027 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 持股5%以上的股东XX保证向本公司提供的信息内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示：持有本公司股份476,697股（占公司总股本比例0.3782%）的高级管理 人员李庆先生计划自本公告发布之日起十五个交易日后的三个月内以集中竞价方式减 持本公司股份，减持总数不超过119,174股（占公司总股本比例0.0945%）。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 江苏爱朋医疗科技股份有限公司（以下简称"公司"）于近日收到高级管理人员李 庆先生出具的《关于股份减持计划告知函》，现将有关情况公告如下： 一、股东的基本情况 | 股东名称 | 职务 | 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 所持公司股份数量（股） | 占公 ...

Investment Rating - The investment rating for the computer industry is optimistic (maintained) [1] Core Insights - The brain-computer interface (BCI) market has significant potential, with global medical applications expected to reach $40 billion by 2030 and $145 billion by 2040 [5][36] - The technology is maturing, with companies like Neuralink receiving FDA approval for human trials, indicating a shift from concept to practical application [6][8] - Policy support is increasing, with various regions in China implementing plans to accelerate the commercialization of BCI technologies [7][45] Summary by Sections 1. Brain-Computer Interface: Continuous Breakthrough - BCI creates a communication channel between the brain and external devices, enabling direct information exchange [17] - The global BCI market was valued at $2.35 billion in 2023, with a projected CAGR of 16.55% from 2023 to 2033 [35] 2. Policy and Technology Resonance: Bright Commercial Prospects for BCI 2.1 Policy: BCI Medical Pricing Implementation Accelerates Commercialization - Major countries are investing in BCI research, with the U.S. and EU leading in funding and project initiatives [41][44] - China's government has issued multiple directives to guide BCI development, including the establishment of independent pricing for BCI services [45][46] 2.2 Technology: Positive Progress in Clinical Trials, Approaching Industrialization - The BCI system faces numerous technical barriers, particularly in balancing performance and commercial viability [48] - China's BCI sector is rapidly advancing, with increasing publications and patents in the field [51][52] 3. Beneficiary Companies 3.1 Neuralink: Pioneer in Invasive BCI Technology - Neuralink is leading in invasive BCI technology, having initiated human trials and planning further patient implants [55][66] 3.2 Strong Brain Technology: Leader in Non-Invasive BCI - Strong Brain Technology focuses on non-invasive BCI solutions, having developed multiple products and secured significant funding [67][69] 3.3 Rock Mountain Technology: Forward-Looking Layout of Brainwave Large Models - Rock Mountain Technology is developing brainwave large models to enhance human-computer interaction systems [80]

Core Viewpoint - The brain-computer interface (BCI) sector is experiencing significant growth, driven by advancements from companies like Neuralink and recent breakthroughs in China, indicating a potential commercialization of BCI technology in the near future [2][4][5]. Group 1: Neuralink Developments - Neuralink has showcased its latest research and product development, with 7 participants currently using the device for an average of 50 hours per week, peaking over 100 hours [2]. - The company plans to implant devices in the speech cortex by the end of 2025 to decode silent speech from brain signals, and aims to increase electrode channels to 3,000 by 2026 to explore restoring vision [2][3]. - By 2028, Neuralink anticipates implanting over 25,000 electrodes to address mental health issues and explore integration with AI, potentially allowing humans to control robots directly [3]. Group 2: Market Potential and Growth - The global BCI market is projected to grow from $2.62 billion in 2024 to approximately $12.4 billion by 2034, with a compound annual growth rate (CAGR) of 17.35% [4]. - The BCI technology is recognized as one of the most disruptive technologies of the 21st century, with expectations for a surge in medical product applications over the next 5 to 10 years [4]. Group 3: Domestic Developments in China - Recent successful trials in China, including the first invasive BCI-assisted rehabilitation for a stroke patient, highlight the rapid advancement of BCI technology towards commercialization [4]. - The "Beijing Brain Institute" has developed a flexible, high-throughput, semi-invasive BCI system that has entered clinical trials, marking significant progress in the field [4]. Group 4: Industry Insights - The domestic BCI industry is benefiting from technological breakthroughs and supportive government policies, which are expected to accelerate the commercialization process [5]. - BCI products are categorized into non-invasive and invasive types, with non-invasive products leading in commercialization, while invasive products are still in clinical research stages [6]. - Despite the promising outlook, the BCI industry faces challenges related to safety, regulatory approval, and the need for foundational research [6][7].

Market Overview - The A-share market saw all three major indices rise in the morning session, with the Shanghai Composite Index up 0.2%, the Shenzhen Component Index up 0.54%, and the ChiNext Index up 0.93% [1] - The total market turnover reached 932.6 billion yuan, a decrease of 81.1 billion yuan compared to the previous day, with over 3,500 stocks rising [1] Sector Performance - The gaming, military, brain-computer interface, and photolithography concept stocks led the gains, while the banking, securities, and dairy sectors experienced declines [3] - Notable stocks in the military sector included Hengyu Xintong (300965), Chenxi Aviation (300581), and Zhongbing Hongjian (000519), all of which hit the daily limit [3] - The gaming sector saw significant increases with Kaiying Network (002517) and Giant Network (002558) both reaching the daily limit [3] - Photolithography concept stocks were active, with Blue Eagle Equipment (300293) hitting the daily limit, along with Kaimete Gas (002549) and Zhongci Electronics (003031) [3] - The innovative drug sector rebounded, with Zhaoyan New Drug (603127) also hitting the daily limit [3] - The banking and securities sectors faced early declines, with Guosheng Jinkong (002670) dropping over 5% [3] Hot Stocks - The strongest sectors included new energy vehicles, military, and specialized innovative companies, with multiple stocks hitting daily limits [8][9][10] - In the new energy vehicle sector, 16 stocks reached the daily limit, with the highest consecutive limit being 9 days [8] - The military sector had 14 stocks hitting the daily limit, with the highest consecutive limit also being 9 days [9] - The specialized innovative sector had 13 stocks hitting the daily limit, with a maximum of 3 consecutive limits [10] Sector Insights - The military equipment sector is expected to benefit from increasing global military trade demand and domestic military modernization efforts, potentially leading to a dual boost in fundamentals and industry valuations [12] - The gaming sector is supported by a record number of game approvals, indicating regulatory support for healthy industry development [13] - The brain-computer interface sector is gaining attention due to advancements from Neuralink, with significant usage data reported from trial participants [14] - The digital currency sector is poised for growth as Hong Kong aims to enhance cross-border payment efficiency through stablecoins, with new regulations set to take effect [15]

Group 1 - The A-share brain-computer interface sector opened high, with Jihua Group hitting the daily limit up [1] - Aipeng Medical rose over 7%, indicating strong investor interest [1] - Other companies such as Innovation Medical, Nanjing Panda, and Sanbo Brain Science also experienced gains [1]

证券代码：300753 证券简称：爱朋医疗 公告编号：2025-026 江苏爱朋医疗科技股份有限公司 关于控股股东、实际控制人部分股份质押及解除质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 江苏爱朋医疗科技股份有限公司（以下简称"公司"）于近日收到公司控股股 东、实际控制人王凝宇先生通知，获悉其所持有本公司的部分股份办理了质押及解 除质押，具体事项如下： 一、股东股份质押基本情况 1、股东股份质押基本情况 | 股东 | 是否为控股 股东或第一 | 本次质押 | 占其所 | 占公 司总 | 是否 | 是否 为补 | | | | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 大股东及其 | 数量 | 持股份 | 股本 | 为限 | 充质 | 质押起始日 | 质押到期日 | 质权人 | 用途 | | | | （股） | 比例 | | 售股 | | | | | | | | 一致行动人 | | | 比例 | | 押 | | | | | | 王凝 ...

Market Overview - The three major A-share indices showed mixed performance in the morning session, with the Shanghai Composite Index up by 0.08%, the Shenzhen Component Index down by 0.19%, and the ChiNext Index down by 0.56% [1] - The total market turnover for the half-day was 686.3 billion yuan, a decrease of 119.6 billion yuan compared to the previous day, with over 3,200 stocks in the market showing declines [1] Sector Performance - The solid-state battery sector led the gains, with stocks such as Haike Energy, Nord Shares, Xiangtan Electric, and Binhai Energy hitting the daily limit [2] - The photovoltaic sector also performed well, with companies like Saiwu Technology and GCL-Poly Energy reaching the daily limit [2] - The liquor sector saw a rebound, with Huangtai Liquor hitting the daily limit and Yingjia Gongjiu and Jinzhongzi Liquor rising over 5% [2] - Conversely, the brain-computer interface sector faced significant declines, with Aipeng Medical dropping over 10% [2] - The short drama game sector experienced collective adjustments, with multiple stocks such as Yuanlong Yatu and Chuanwang Media falling over 5% [2] Notable Stocks and Trends - The solid-state battery sector is highlighted with companies like Haike Energy and Nord Shares making significant advancements, including the completion of pilot lines and production plans [8] - The photovoltaic sector is expected to see a reduction in production in Q3, with a projected decrease in operating rates by 10%-15% [8] - The liquor industry is entering a new phase in its inventory cycle, with companies that adapt to fast-moving consumer goods strategies gaining competitive advantages [8] Hot Stocks - Shandong Molong has achieved a six-day limit-up streak [4] - Companies like Meihua Shihua and Xiangtan Electric have recorded two consecutive limit-ups [5] - The chip concept sector saw nine stocks hitting the daily limit, with notable performers including Zhongjing Electronics and Xingye Shares [6]

Group 1 - The brain-computer interface sector has experienced a significant surge, with companies like Innovation Medical (002173) hitting the daily limit up [1] - Other companies such as Beikang, Aipeng Medical (300753), Nanjing Panda (600775), Entropy Technology (301330), and Sanbo Brain Science (301293) have also seen notable increases in their stock prices [1] - There is a notable influx of dark pool capital into these stocks, indicating potential investor interest and activity [1]